ASSET | DATE | % RETURN |
---|---|---|
Eightco (OCTO) | 4/1/2023 - 5/31/2023 | 2,044.58% |
CXApp (CXAI) | 4/1/2023 - 5/31/2023 | 598.86% |
Dogwood Therapeutics (DWTX) | 4/1/2023 - 5/31/2023 | 382.47% |
SAB Biotherapeutics (SABSW) | 4/1/2023 - 5/31/2023 | 316.67% |
CalciMedica, Inc Common Stock (CALC) | 4/1/2023 - 5/31/2023 | 310% |
SunCar Technology (SDA) | 4/1/2023 - 5/31/2023 | 300.47% |
P3 Health Partners (PIIIW) | 4/1/2023 - 5/31/2023 | 287.02% |
Applied Digital (APLD) | 4/1/2023 - 5/31/2023 | 268.72% |
Minerva Neurosciences (NERV) | 4/1/2023 - 5/31/2023 | 264.02% |
P3 Health Partners (PIII) | 4/1/2023 - 5/31/2023 | 255.26% |
Corvus Pharmaceuticals (CRVS) | 4/1/2023 - 5/31/2023 | 245.45% |
US GoldMining Inc Warrant (USGOW) | 4/1/2023 - 5/31/2023 | 233.27% |
Nano X Imaging (NNOX) | 4/1/2023 - 5/31/2023 | 208.85% |
9F (JFU) | 4/1/2023 - 5/31/2023 | 205.52% |
Wearable Devices (WLDS) | 4/1/2023 - 5/31/2023 | 196.97% |
enGene Holdings Inc Warrants (ENGNW) | 4/1/2023 - 5/31/2023 | 192.65% |
GSI Technology (GSIT) | 4/1/2023 - 5/31/2023 | 192.42% |
Evolv Technologies (EVLVW) | 4/1/2023 - 5/31/2023 | 185.3% |
NexGel Inc Warrant (NXGLW) | 4/1/2023 - 5/31/2023 | 184.29% |
Leap Therapeutics (LPTX) | 4/1/2023 - 5/31/2023 | 157.97% |
Tenaya Therapeutics (TNYA) | 4/1/2023 - 5/31/2023 | 154.42% |
Shengfeng Development Limited Class A Ordinary Shares (SFWL) | 4/1/2023 - 5/31/2023 | 153.42% |
Soleno Therapeutics (SLNO) | 4/1/2023 - 5/31/2023 | 150.95% |
NextPlat (NXPLW) | 4/1/2023 - 5/31/2023 | 149.6% |
Bioventus (BVS) | 4/1/2023 - 5/31/2023 | 148.17% |